SelSym Biotech
PrivateLast Round
Seed
Jul 2, 2026
Total Funding Raised
$7.34M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SelSym Biotech operates in Healthcare & Life Sciences and is based in Raleigh, North Carolina. Its latest recorded funding round was a Grant round in April 2024.
SelSym Biotech is a biotechnology company developing synthetic platelet-mimetic therapeutics for hemorrhage control and wound healing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SelSym Biotech Comparables
Compare SelSym Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hemostatics Pharmaceuticals S.L. | 61% | |
| Melanyze, Inc. | 53% |
For institutional investors. Book with your work email.
SelSym Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 2, 2026 | ||||
| Seed | Apr 16, 2024 | ||||
| Grant | Apr 16, 2024 | ||||
| Grant | Sep 22, 2022 | ||||
| Debt | Jun 1, 2022 | ||||
Grant | Sep 15, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SelSym Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| U.S. Department of War | Grant |
| Persephoni BioSciences | Seed |
| North Carolina Biotechnology Center | Debt |
| National Heart, Lung, and Blood Institute | Grant |
| One North Carolina Small Business Program | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
$500K Seed Round raised.
- Jul 16, 2025
Grew 50% QoQ from 6 to 9 employees.
For institutional investors. Book with your work email.
SelSym Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SelSym Biotech's valuation, stock price, and market status.
Is SelSym Biotech a public or private company?
SelSym Biotech is a private company.
What is the current stock price of SelSym Biotech?
SelSym Biotech is a private company, so its shares have no public market price. Caplight tracks SelSym Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SelSym Biotech worth (valuation)?
Valuation information for SelSym Biotech is not publicly available.
Can I buy SelSym Biotech stock?
SelSym Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SelSym Biotech's last funding round?
SelSym Biotech's most recent funding round was Seed on July 2, 2026.
Who are the main investors in SelSym Biotech?
Key investors in SelSym Biotech include Persephoni BioSciences.
Will SelSym Biotech IPO soon?
No public IPO plans have been announced for SelSym Biotech.
How can I track SelSym Biotech secondary market activity?
Caplight tracks bids, offers, and trades in SelSym Biotech's shares on secondary markets.